Jacobs Levy Equity Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-112,165
| Closed | -$913K | – | 987 |
|
|
2024
Q3 | $913K | Sell |
112,165
-688,905
| -86% | -$5.61M | ﹤0.01% | 737 |
|
|
2024
Q2 | $5.12M | Buy |
801,070
+62,569
| +8% | +$400K | 0.02% | 454 |
|
|
2024
Q1 | $5.56M | Sell |
738,501
-5,136
| -0.7% | -$38.7K | 0.02% | 408 |
|
|
2023
Q4 | $6.89M | Sell |
743,637
-19,013
| -2% | -$176K | 0.03% | 365 |
|
|
2023
Q3 | $7.72M | Sell |
762,650
-271,383
| -26% | -$2.75M | 0.05% | 298 |
|
|
2023
Q2 | $12.9M | Sell |
1,034,033
-185,662
| -15% | -$2.32M | 0.07% | 247 |
|
|
2023
Q1 | $14.2M | Sell |
1,219,695
-8,794
| -0.7% | -$103K | 0.09% | 235 |
|
|
2022
Q4 | $13.1M | Buy |
1,228,489
+690,711
| +128% | +$7.34M | 0.09% | 246 |
|
|
2022
Q3 | $5.22M | Buy |
+537,778
| New | +$5.22M | 0.04% | 387 |
|